Andrea T. Flynn, MD

female silhouette icon
Andrea T. Flynn, MD, is an attending physician in the Cancer Center at Children's Hospital of Philadelphia.

Locations: Main Hospital

Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Medical School

MD - University of Michigan, Ann Arbor, MI


Pediatrics - Children's Hospital of Philadelphia, Philadelphia, PA


Pediatric Hematology/Oncology - Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification

Pediatrics – American Board of Pediatrics

Graduate Degree

MS in Pharmacology - Thomas Jefferson University, Philadelphia, PA

Titles and Academic Titles

Attending Physician

Instructor, Perelman School of Medicine at the University of Pennsylvania

Departments and Services




Orenstein L., Coughlin C., Flynn A., Pillai V., Boo M., Wertheim G., Treat J., Teachey D. Severe Mucha-Habermann-like Ulceronecrotic Skin Disease in T-cell ALL Responsive to Basiliximab and Stem Cell Transplant. Pediatric Dermatology, 2017 Sep;34(5):e265-e270.

Flynn A., Fox E. Evolving paradigms for new agent development in pediatric oncology. Current Opinions in Pediatrics, Nov 2017 [Epub ahead of print]

Posters and Presentations


Flynn A, Hogarty M. ODC1 Amplification and Polyamine Depletion in Neuroblastoma: Forming a Responder Hypothesis. Fifth Annual Meeting of NICHD and NICHD-NIGMS T32 Trainees in Pediatric Clinical Pharmacology, September 2016.

Flynn A, Benavides A, Vu A, Liu K, Scadden E, Attiyeh E, Haber M, Norris M, Bassiri H, Hogarty M. Effects on tumor cells and the immune microenvironment may both contribute to the anti-tumor activities of DFMO in neuroblastoma in pre-clinical models. Advances in Neuroblastoma Research Congress, June 2016.

Flynn AT. Participation of Pediatric Patients in Oncology Research. Presented at: Ethics Conference, Department of Pharmacology Seminars in Human investigation, Thomas Jefferson University; 2016 Sep; Philadelphia, PA.

Flynn AT. Polyamine Depletion in Neuroblastoma: Forming a Testable Responder Hypothesis. Presented at: Annual Pediatric Clinical Pharmacology T32 meeting; 2016 Sep; Bethesda, MD.

Flynn AT. ODC1 Amplification and Polyamine Dependence in Neuroblastoma: Forming a Responder Hypothesis. Presented at: Post-Doctoral Seminar, Poster Day Winners Symposium, The Children’s Hospital of Philadelphia; 2016 May; Philadelphia, PA.

Awards and Honors

2016, Basic Science Award, CHOP Research Poster Day
2015, Clinical Pharmacology T32 Awardee, Children’s Hospital of Philadelphia
2011, Distinction in Service Award, University of Michigan Medical School
2007, Henry Kumpf Memorial Award, Rensselaer Polytechnic Institute, Department of Athletics
2007, Academic All-American At Large, NCAA Field Hockey/Lacrosse, ESPN The Magazine

Editorial and Academic Positions

Academic and Institutional Committees

2011-present, Graduate Medical Education Committee, Resident/Fellow Representative

Leadership and Memberships

2016-present, American College of Clinical Pharmacology (Member)
2015-present, Advances in Neuroblastoma Research Association (Member)
2015-present, American Association for Cancer Research (Member)
2015-present, American Society of Pediatric Hematology/Oncology (Member)
2014-present, Children’s Oncology Group (Member)